Adjuvant endocrinotherapy of postmenopausal patients with breast cancer

by V. F. Semiglazov, A. A. Malodusheva, V. G. Ivanov, P. V. Krivorotko
Published 2014-09-01

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer

by T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov
Published 2014-07-01

Comparison of cosmetic results after treatment in women with breast cancer who received additional radiation to the tumor bed

by I. A. Akulova, S. N. Novikov, A. I. Tseluyko, A. V. Chernaya, Zh. V. Bryantseva, P. V. Krivorotko, S. V. Kanaev
Published 2021-01-01

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)

by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev
Published 2015-09-01

Future prospects for breast cancer immunotherapy

by V. F. Semiglazov, A. I. Tseluiko, R. V. Donskikh, P. V. Krivorotko, G. A. Dashyan, V. V. Semiglazov, A. V. Komyakhov
Published 2018-11-01

Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemot...

by P V Krivorotko, O N Burdaeva, M N Nechaeva, M A Frolova, M V Kopp, A A Abrosimova, R A Ivanov
Published 2015-06-01

Post-neoadjuvant treatment of breast cancer

by V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko
Published 2020-07-01

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer

by T Yu Semiglazova, G A Dashyan, V V Semiglazov, A S Zhabina, M A Osipov, Z S Kotova, V V Klimenko, P V Krivorotko, V F Semiglazov
Published 2015-03-01

The role of digital mammography, scintimammography with ^99mTc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer

by A. V. Chernaya, P. I. Krzhivitskiy, E. A. Busko, P. V. Krivorotko, A. S. Artemyeva, N. S. Popova, V. V. Danilov, V. F. Semiglazov, S. N. Novikov, S. V. Kanaev
Published 2020-03-01

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe...

by E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov
Published 2017-02-01

New prospects in the use of Kadcyla® in breast cancer

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova
Published 2015-11-01

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER

by P. V. Krivorotko, E. K. Zhiltsova, L. P. Gigolaeva, Sh. M. Khadzhimatova, G. A. Dashyan, K. Yu. Zernov, E. S. Trufanova, А. S. Artemyeva, A. G. Kudaibergenova, V. F. Semiglazov
Published 2017-12-01

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases

by T.  Yu.  Semiglazova, S.  M.  Sharashenidze, S.  N.  Kerimova, V.   V. Klimenko, A. Yu.  Malygin, G.  A.  Dashyan, R.   M. Paltuev, V.  V.  Semiglazov, P.   V. Krivorotko, S.  N.  Novikov, V.   F. Semiglazov
Published 2021-06-01

New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer

by T Yu Semiglazova, V A Klyuge, V V Semiglazov, G M Teletaeva, P V Krivorotko, G A Dashyan, R M Paltuev, E V Tkachenko, R V Donskikh, V F Semiglazov
Published 2016-06-01

Neoadjuvant treatment for breast cancer

by V. F. Semiglazov, V. V. Semiglazov, R. M. Paltuev, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, A. V. Komyakhov, Zh. V. Bryantseva, K. S. Nikolaev, D. Ye. Shchedrin, A. M. Yermochenkova
Published 2014-07-01

EVALUATION OF MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES OF BREAST CARCINOMAS AFTER NEOADJUVANT SYSTEMIC THERAPY

by V. О. Bashlyk, V. F. Semiglazov, A. G. Kudaybergenova, A. S. Artem’eva, T. Yu. Semiglazova, V. S. Chirskiy, A. V. Komyakho, P. V. Krivorot’ko, V. V. Klimenko, Sh. M. Khadzhimatova, A. I. Tseluyko, S. S. Ereschenko
Published 2018-04-01

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Published 2016-06-01

Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy

by V F Semiglazov, E K Zhil'tsova, V V Semiglazov, V G Ivanov, G A Dashyan, A A Klettsel', A A Bozhok, K S Nurgaziev, E E Topuzov, P V Krivorot'ko, E V Tsyrlina, L M Bershteyn
Published 2003-12-01

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER

by V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Published 2018-07-01

Immunology and immunotherapy in the complex treatment of malignant tumors

by V. F. Semiglazov, A. I. Tseluiko, I. A. Baldueva, T. L. Nekhaeva, A. S. Artemyeva, A. G. Kudaybergenova, S. A. Protsenko, A. V. Novik, V. V. Semiglazov, R. V. Donskikh, T. Yu. Semiglazova, R. S. Pesotskiy, V. S. Apollonova, P. V. Krivorotko, A. M. Belyaev
Published 2021-04-01